Literature DB >> 6659490

Prolactin-secreting pituitary adenomas.

M C Martin, E D Schriock, R B Jaffe.   

Abstract

Prolactin-secreting pituitary adenoma is a common cause of gynecologic problems that include oligomenorrhea, infertility, amenorrhea and galactorrhea. Diagnosis requires a combination of endocrine testing and radiologic evaluation. The diagnosis of macroadenomas is usually straightforward and these large tumors may be associated with mass effects such as severe headache, nerve palsies or visual changes. Microadenomas may be more subtle in presentation, and the diagnosis of hyperprolactinemia without radiologic evidence of a tumor frequently is problematic. The management of prolactin-secreting adenoma remains controversial, with no clear consensus or indication for surgical versus medical treatment. Surgical intervention is a realistic option for those patients who have access to an experienced neurosurgeon and who have tumor characteristics that offer a reasonable hope for cure. Many questions remain to be answered, including the cause, natural history of development and the optimum treatment for individual cases.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6659490      PMCID: PMC1010965     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  81 in total

Review 1.  Ultrastructure of human sella tumors. Correlations of clinical findings and morphology.

Authors:  A M Landolt
Journal:  Acta Neurochir (Wien)       Date:  1975       Impact factor: 2.216

Review 2.  Prolactin secreting pituitary adenomas in women with amenorrhea or galactorrhea.

Authors:  W R Keye; R J Chang; R B Jaffe
Journal:  Obstet Gynecol Surv       Date:  1977-11       Impact factor: 2.347

3.  Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours.

Authors:  A E Pontiroli; L Falsetti; A M Voltolini; M Alberetto; G Pellicciotta; A de Pasqua; A M Girardi; G Pozza
Journal:  Acta Endocrinol (Copenh)       Date:  1981-11

4.  Abnormal prolactin responsivity to dopaminergic suppression in hyperprolactinemic patients.

Authors:  S Bansal; L A Lee; P D Woolf
Journal:  Am J Med       Date:  1981-12       Impact factor: 4.965

5.  The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.

Authors:  H G Friesen; G Tolis
Journal:  Clin Endocrinol (Oxf)       Date:  1977       Impact factor: 3.478

6.  Rapid deterioration of visual fields during bromocriptine-induced pregnancy in a patient with a pituitary adenoma.

Authors:  J T Van Dalen; E L Greve
Journal:  Br J Ophthalmol       Date:  1977-11       Impact factor: 4.638

7.  Coexisting pituitary adenomas and partially empty sellas.

Authors:  J N Domingue; S D Wing; C B Wilson
Journal:  J Neurosurg       Date:  1978-01       Impact factor: 5.115

8.  Nomifensine: diagnostic test in hyperprolactinemic states.

Authors:  E E Müller; A R Genazzani; S Murru
Journal:  J Clin Endocrinol Metab       Date:  1978-12       Impact factor: 5.958

9.  Acute prolactin release triggered by feeding.

Authors:  M E Quigley; J F Ropert; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

10.  Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.

Authors:  R J Chang; W R Keye; J R Young; C B Wilson; R B Jaffe
Journal:  Am J Obstet Gynecol       Date:  1977-06-15       Impact factor: 8.661

View more
  1 in total

1.  Reversal of severe osteopenia in a patient with hyperprolactinemia treated with bromocriptine.

Authors:  J S Lindberg; F O Kolb; R A Blau; M R Powell
Journal:  West J Med       Date:  1988-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.